Zuo M. Comparison of Efficacy and Safety of Imatinib and Dasatinib in the Treatment of Chronic-phase Chronic Myeloid Leukemia. HSET [Internet]. 2023 Dec. 29 [cited 2026 Aug. 2];74:1807-16. Available from: https://drpress.org/ojs/index.php/HSET/article/view/16082